Send a Tweet
Most Popular Choices
Share on Facebook 22 Share on Twitter Printer Friendly Page More Sharing
OpEdNews Op Eds    H4'ed 10/3/16

Kenya has done it, when will the rest of us?

By       (Page 1 of 3 pages)   No comments
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)
Shobha Shukla - CNS (Citizen News Service)
Dr Immaculate Kathure, Child TB Services Coordinator, Kenya National TB Programme
Dr Immaculate Kathure, Child TB Services Coordinator, Kenya National TB Programme
(Image by CNS (Citizen News Service))
  Details   DMCA

Yes, this question merits serious thought, even as Kenya Ministry of Health recently announced the launch of fixed dose combination (FDC) of first-ever child-friendly TB medicines, making Kenya the first country in the world to roll out these products nationally. Starting 1st of October 2016, all children in Kenya, who will be initiated on TB treatment, will be given the improved formulation that is easier for caregivers to give and for children to take, and is expected to help improve treatment outcomes of childhood TB.

It was on 2nd December, 2015, just ahead of 46th Union World Conference on Lung Health in Cape Town, South Africa, that the world's first appropriate, child-friendly FDC medicines to treat children suffering from drug-sensitive TB were launched, thanks to the untiring efforts of TB Alliance and its partners: WHO, UNITAID and USAID.

During the launch almost 10 months back, Dr Enos Masini, Kenya's National Tuberculosis Programme manager, had said, "Childhood TB is a problem that can be solved when we choose to act. We need to make sure all children with TB are diagnosed and treated with the best medicines possible. I am proud to say Kenya plans to adopt these new products for our children immediately, which will greatly improve our response to treating drug-sensitive TB."

Well, exactly 10 months down the line, Kenya has honoured its promise. What about the rest of the world? How long will other countries take to introduce the new improved paediatric TB medicines?

Citizen News Service (CNS) interviewed (via email) Dr Immaculate Kathure, Child TB Services Coordinator of the Kenya National TB Programme. Here are excerpts from Dr Kathure's interview:

What prompted Kenya to lead introduction of new formulation?

Dr Immaculate Kathure: "The Kenya government's national TB programme has a commitment to ensure that we reduce the burden of lung disease in Kenya, rendering Kenya free of TB. This is through the provision of people-centric, universally accessible, acceptable and affordable quality services. Childhood TB is one of the key services we focus on, considering the vulnerability of children to TB. The government is also committed to reducing mortality among children and successful treatment of TB is one of the strategies to ensure we realize this goal.

Children with TB and their caregivers have over the years struggled with TB treatment that is complex - they had to split and crush multiple pills to achieve the right dose for children and children had to swallow these water insoluble bitter-tasting pills. Moreover it was difficult to determine whether children were receiving the correct dose of medicines or not. All this made TB treatment ineffective and increased the rates of drug resistant TB in children. We went for the improved medicines to avert this."

Next Page  1  |  2  |  3

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Well Said 1   Valuable 1  
Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: or @cns_health or
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
   (Opens new browser window)

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Progress made but work remains on firewalling health policy from tobacco industry

Youth Changemakers at the forefront of advocating for sexual health and rights

A bouquet of novel compounds: New treatment options for HIV

To View Comments or Join the Conversation:

Tell A Friend